Status:
COMPLETED
Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents
Lead Sponsor:
Catherine Martin, MD
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Tobacco Use Disorder
Eligibility:
All Genders
16-40 years
Phase:
PHASE1
Brief Summary
Nicotine is one of the most widely abused substances in the United States. Nicotine replacement therapy (NRT) is currently an effective treatment for nicotine dependence; however, even with NRT most p...
Detailed Description
NRT is a critical part of treating nicotine withdrawal symptoms, such as cravings, sleeplessness, poor concentration, and anxiety. The addition of modafinil, a promising pharmacologic agent, may enhan...
Eligibility Criteria
Inclusion
- Smokes 10 or more cigarettes per day
Exclusion
- Current use of any medication for a psychiatric disorder
- Positive drug screen test
- Uses smokeless tobacco
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00258479
Start Date
June 1 2003
End Date
December 1 2011
Last Update
May 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky
Lexington, Kentucky, United States, 40509